Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study.
Ann Hematol
; 102(11): 3039-3047, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37682325
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Erythropoietin
/
Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Germany